Clinical Trial Update: Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial to evaluate cognitive improvement in patients with schizophrenia. The study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED